Q4 2021 Holdings
Filed 2022-02-14 | 76 holdings | $500.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $223.5M | 5,523,358 | 44.7% |
| Alector Inc(ALEC) | COM | 014442107 | $103.1M | 4,994,970 | 20.6% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $71.4M | 3,060,593 | 14.3% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $48.1M | 5,376,134 | 9.6% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $16.8M | 590,169 | 3.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $16.6M | 98,146 | 3.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $10.7M | 130,300 | 2.1% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $6.4M | 200,000 | 1.3% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $1.1M | 75,000 | 0.2% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $557.4K | 11,284,280 | 0.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $261.4K | 7,521,024 | 0.1% |
| Xencor Inc(XNCR) | COM | 98401F105 | $196.8K | 4,906,106 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $190.7K | 4,033,882 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $187.2K | 3,951,566 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $122.6K | 2,224,403 | 0.0% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $118.1K | 13,896,543 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $90.3K | 2,639,706 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $81.7K | 1,077,483 | 0.0% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $77.3K | 6,012,232 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $65.6K | 2,759,505 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $60.7K | 1,303,157 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $54.6K | 1,779,084 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $52.1K | 3,724,437 | 0.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $51.0K | 3,468,944 | 0.0% |
| 2Seventy BIO ORD(TSVT*) | COMMON STOCK ADDED | 901384107 | $49.1K | 1,917,063 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $46.1K | 2,152,997 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $40.0K | 940,636 | 0.0% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $27.9K | 1,411,975 | 0.0% |
| Pardes Biosciences ORD | COM ADDED | 69945Q105 | $26.1K | 1,597,139 | 0.0% |
| Ventyx Biosciences ORD(VTYX) | COM ADDED | 92332V107 | $25.8K | 1,300,000 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $19.5K | 1,279,175 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $19.5K | 6,082,200 | 0.0% |
| Akouos Inc | COM | 00973J101 | $16.8K | 1,975,984 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $16.1K | 9,202,702 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $15.8K | 392,000 | 0.0% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $14.3K | 307,594 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $14.2K | 1,300,000 | 0.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $10.9K | 700,000 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $9.9K | 882,176 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $9.7K | 1,140,819 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $9.6K | 3,557,507 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $9.0K | 309,540 | 0.0% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $8.6K | 688,900 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $8.2K | 963,333 | 0.0% |
| Silverback Therapeutics Inc(SPRY) | COM | 82835W108 | $7.1K | 1,060,010 | 0.0% |
| Frazier Lifesciences Acqu Co | SHS | G3710A105 | $5.7K | 587,615 | 0.0% |
| Applied Molecular Trans Inc | COM | 03824M109 | $5.6K | 400,000 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $5.3K | 387,357 | 0.0% |
| Jiya Acquisition Corp | COM CL A | 47760M102 | $4.9K | 500,000 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $4.1K | 860,619 | 0.0% |